Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U), a pioneer in enabling technologies for the pharmaceutical and chemical sectors, has successfully installed its second Self-Driving Laboratory ("SDL") at Pfizer. This installation, completed in January 2026, is part of a multi-year agreement that enhances their collaborative efforts.
The newly installed SDL represents a significant advancement in the shift from collaborative research and development (R&D) to potential full-scale implementation. This cutting-edge platform is designed to drastically shorten development timelines and deliver substantial cost savings, utilizing artificial intelligence, advanced process analytical technology, and robotic automation to revolutionize chemistry research.
Understanding the Self-Driving Laboratory ("SDL")
The SDL operates as a fixed-position Physical AI platform, seamlessly integrating collaborative robotics, real-time inline analytics (Process Analytical Technology, or PAT), and machine-learning-driven experimental design within a continuous, autonomous closed-loop workflow. This system autonomously sets up chemical reactions, measures kinetics in real time, and identifies the next optimal experiment without researcher intervention, allowing for around-the-clock operation across multiple reaction vessels. The SDL enhances experimental throughput by up to 100 times compared to traditional manual methods, significantly expediting the development of chemical synthesis techniques.
Executive Insights
Henry Dubina, CEO of Telescope Innovations, remarked, "The installation of our second SDL at one of the world's largest pharmaceutical companies underscores the strength of our ongoing partnership with Pfizer. The SDL not only aims to yield substantial cost savings during drug development but also seeks to accelerate the introduction of new innovations into the market."
Dr. Jason Hein, Founder and CTO, added, "With this second SDL deployment, we are pleased to continue demonstrating Physical AI in action, transitioning from digital models to real-world chemistry. The platform generates unique insights unattainable through simulation alone, and its core architecture can be adapted to any field requiring rapid optimization of chemical or materials processes, from pharmaceutical innovations to advanced manufacturing and beyond."
Telescope Innovations Corp. specializes in intelligent automation and advanced manufacturing technologies for chemicals. The Company offers enabling technologies such as flexible robotic platforms and AI software, enhancing experimental throughput, efficiency, and data quality. Their Self-Driving Labs are fully autonomous platforms that outpace traditional methods in planning, executing, and analyzing experiments. Bio-pharmaceutical, specialty chemical, and advanced materials industries leverage Telescope's solutions to speed up the development of chemical processes, effectively reducing time and costs from lab to market. For more information, visit telescopeinnovations.com.
For inquiries, contact Henry Dubina, Chief Executive Officer, at henry.dubina@telescopeinn.com or call 778-262-1113.
This announcement contains forward-looking statements under applicable Canadian securities laws, which involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. The Company does not undertake to update any forward-looking information except as required by law.